The GBA Multimodal Study in Parkinson's Disease
This observational study is looking at how changes in the GBA gene are linked to Parkinson's disease. Researchers will use special brain scans called PET scans to look at dopamine, acetylcholine (a brain chemical), and tau protein (a protein that can build up in the brain) in people with and without Parkinson's disease who have a GBA gene mutation. They will also analyze typing patterns using a computer or touch-screen device. The goal is to understand the molecular and clinical reasons behind the connection between GBA mutations and Parkinson's disease. You may be able to join if you are 18-80 years old and have a specific GBA gene mutation. The study is currently unclear on its recruitment status.
- Study design
- This is an observational study planning to enroll 25 participants. It will include 10 people with Parkinson's disease and a GBA mutation, and 15 people with a GBA mutation but no Parkinson's symptoms.
- What's involved
- Participants will have a clinical evaluation, a typing session, a brain MRI, and three PET scans.
- Compensation
- Not stated in the trial record.
- Follow-up
- Not specified.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
The GBA Multimodal Study in Parkinson's Disease
At a glance
Conditions
NCT04101968
Where you'd take part
This study runs at 3 sites. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.
Oregon Health & Science University
Portland, Oregonno site contact published
Pacific Parkinson's Research Centre | University of British Columbia
Vancouver, British Columbia, Canadano site contact published
University of Washington
Seattle, Washingtonno site contact published
Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.
Study leadership
- Michele Matarazzo, MD · PRINCIPAL_INVESTIGATOR · Pacific Parkinson's Research Centre | University of British Columbia
- A. Jon Stoessl, CM, MD, FRCPC, FCAHS · PRINCIPAL_INVESTIGATOR · Pacific Parkinson's Research Centre | University of British Columbia
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
Want this trial checked against your situation?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Acetylcholinesterase activitybaseline
11C-PMP PET
- Tau protein depositionbaseline
11C-PBB3 PET
- Dopaminergic denervationbaseline
11C-DTBZ PET
- neuroQWERTY indexbaseline
Typing analysis